Service by

Home Journal Issues Instructions for Authors Editorial Board About Journal Aims & Scope


Original Research Open Access
RMJ. 2013; 38(2): 127-30


Oral Ivermectin as a Therapeutic Agent in Patients with Scabies

Eman M.H. Méabed.

Abstract
Objective: To evaluate oral Ivermectin as a
therapeutic agent to ordinary scabies.
Methodology: Random sample of 50 cases of
ordinary scabies was treated with two oral doses
of Ivermectin, 200 μg/kg one week apart. The
effect of the drug was monitored clinically, by
complete blood count, and confirmed
parasitologically at the time of clinical
presentation and at week 4 of starting treatment.
ELISA and Immunobloting using Sarcoptes
scabiei crude mite extract were applied
to determine the levels of specific IgG and IgE in
patients' sera in comparison with 50 controls.
Results: The reported cure rate was 100%.
However, 8% cases continued to have persistent
itching, accompanying eosionophilia and high IgE
levels.
Conclusion: Ivermectin proved to be effective and
promising drug for treatment of ordinary scabies.
(Rawal Med J 2013; 38:127-130).

Key words: Scabies, Ivermectin, ELISA, Immunoblotting.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Eman M.H. Méabed
on Google
on Google Scholar
Article Statistics
 Viewed: 1473
Downloaded: 317
Cited: 0


REFERENCES
1. Sharma R, Singal A. Topical Permethrin and oralIvermectin in the management of scabies: A prospective,randomized, double blind, controlled study. IJDVL.2O11;77(5): 581-586.
2. Saqib M, Afridi IU, Ali A, Jahangir M. Scabies saftey ofpermetherin and ivermectin. Professional Med J. Feb2012; 19(1):086-092.
3. Khan I, Yasmin R. Ivermectin in the treatment of Scabies.Journal of Pakistan Association of Dermatologists. 2007;17:78-83.
4. Currie BJ, McCarthy JS. Permethrin and Ivermectin forscabies. New Eng J Med. 2010;362:717-25. [DOI via Crossref]   
5. Strong M, Johnstone PW. Intervention for treatingscabies. Cochrane Database Syst Rev. 2007; 3:CD000320.
6. Bachewar NP, Thawani VR, Mali SN, Gharpure KJ,Shingade VP, Dakhale GN. Comparison of safety,efficacy, and cost effectiveness of benzyl benzoate,permethrin, and ivermectin in patients of scabies. Indian JPharmacol. 2009; 41:9-14. [DOI via Crossref]   
7. Katz N, Chaves A, Pellegrino J.A simple device forquantitative stool thick-smear technique inSchistosomiasis mansoni. Rev Inst Med Trop Sao Paulo.1972; 14: 397-400.
8. Michigan Department of Community Health: MDCH.Scabeies prevention and control manual. 2005; Version1.0 online PDF document.
9. Elder BL , Arlian LG , Morgan MS. Sarcoptesscabiei (Acari: Sarcoptidae) Mite Extract ModulatesExpression of Cytokines and Adhesion Molecules byHuman Dermal Microvascular Endothelial Cells. JMed Entomol. 2006; 43(5): 910-915. [DOI via Crossref]   
10. Bradford MM. A rapid and sensitive method for thequantitation of microgram quantities of proteinutilizing the principle of protein-dye binding. AnalBiochem. 1976; 72:248-254 [DOI via Crossref]   
11. Voller A, Bidwell D, Bartlett A. Enzymeimmunoassays in diagnostic medicine. Theory andPractice. Bulletin of the World Health Organization,1976; 53: 55-65.
12. Laemmli UK. Cleavage of structural proteins duringthe assembly of the head of Bacteriophage T4. Nature.1970; 227:680-687. [DOI via Crossref]   
13. Towbin H, Staehelin T, Gordon J. Electrophoretictransfer of proteins from polyacrylamide gels tonitrocellulose sheets: procedure and some applications.Proc. Natl. Acad. Sci. U. S. A 1979;76:4350-4. [DOI via Crossref]   
14. Worth C, Heukelbach J, Fengler G, Walter B, LiesenfeldO, Hengge U, et al. Acute Morbidity Associated withScabies and Other Ectoparasitoses Rapidly ImprovesAfter Treatment with Ivermectin. Pediatr Dermatol2012;29:430-6. [DOI via Crossref]   
15. Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA.Comparative efficacy and safety of topical permethrin,topical ivermectin, and oral ivermectin in patients ofuncomplicated scabies. IJVDL 2012;78:605-10.
16. Sule HM, Thacher TD. Comparison of Ivermectin andBenzyl benzoate lotion for scabies in Nigerian patients.Am J Trop Med Hyg 2007;76:392-5.
17. Goldust M, Rezaee E, Hemayat S. Treatment ofscabies: Comparison of permethrin 5% versusivermectin. J Dermatol 2012;39:545-7. [DOI via Crossref]   
18. Arlian LG, Morgan MS. Serum antibody to Sarcoptesscabiei and house dust mite prior to and during infestationwith S. scabiei. Vet Parasitol 2000;90:315-26. [DOI via Crossref]   
19. Walton SF, Beroukas D, Roberts-TP, Currie BJ. Newinsights into disease pathogenesis in crusted(Norwegian) scabies: the skin immune response incrusted scabies. Br J Dermatol 2008;158:1247-55. [DOI via Crossref]   
20. Arlian LG, Morgan MS, Arends JJ. Immunologic crossreactivity among various strains of Sarcoptes scabiei. JParasitol 1996;82:66-72. [DOI via Crossref]   
21. Arlian LG, Morgan MS, Estes SA, Walton SF, Kemp DJ,Currie BJ. Circulating IgE in patients with ordinary andcrusted scabies. J Med Entomol 2004;41:74-7. [DOI via Crossref]   
22. Walton SF. The immunology of susceptibility andresistance to scabies. Parasite Immunol 2010;32:532-40.
23. Tarigan S. Antibody responses in naïve and sensitizedgoats infested by Sarcoptes scabiei. JITV 2004;9:258-65.

How to Cite this Article
Pubmed Style

Eman M.H. Méabed. Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . RMJ. 2013; 38(2): 127-30.



Web Style

Eman M.H. Méabed. Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . www.scopemed.org/?mno=150125 [Access: October 20, 2017].



AMA (American Medical Association) Style

Eman M.H. Méabed. Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . RMJ. 2013; 38(2): 127-30.



Vancouver/ICMJE Style

Eman M.H. Méabed. Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . RMJ. (2013), [cited October 20, 2017]; 38(2): 127-30.



Harvard Style

Eman M.H. Méabed (2013) Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . RMJ, 38 (2), 127-30.



Turabian Style

Eman M.H. Méabed. 2013. Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . Rawal Medical Journal, 38 (2), 127-30.



Chicago Style

Eman M.H. Méabed. "Oral Ivermectin as a Therapeutic Agent in Patients with Scabies ." Rawal Medical Journal 38 (2013), 127-30.



MLA (The Modern Language Association) Style

Eman M.H. Méabed. "Oral Ivermectin as a Therapeutic Agent in Patients with Scabies ." Rawal Medical Journal 38.2 (2013), 127-30. Print.



APA (American Psychological Association) Style

Eman M.H. Méabed (2013) Oral Ivermectin as a Therapeutic Agent in Patients with Scabies . Rawal Medical Journal, 38 (2), 127-30.




Instructions for Authors

AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

WHO Index Medicus IMEMR,
Emromedex,
Pakmedinet,
ExtraMED and
Scopus

Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council



The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.